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Non-O1/non-O139 nontoxigenic Vibrio cholerae associated with cholera-like 
diarrhea has been reported in Kolkata, India. However, the property involved in the 
pathogenicity of these strains has remained unclear. We examined the character of 
25 non-O1/non-O139 nontoxigenic V. cholerae isolated during 8 years from 2007 
to 2014 in Kolkata. Determination of serogroup showed that the serogroups O6, 
O10, O35, O36, O39, and O70 were represented by two strains in each serogroup, 
and the remaining isolates belonged to different serogroups. To clear the character 
of antibiotic resistance of these isolates, the antibiotic resistance test and the gene 
analysis were performed. According to antimicrobial drug susceptibility testing, 13 
strains were classified as drug resistant. Among them, 10 strains were quinolone 
resistant and 6 of 13 strains were resistance against more than 3 antibiotics. To 
define the genetic background of the antibiotic character of these strains, we 
determined whole-genome sequences of these strains. From the analysis of these 
sequences, it becomes clear that all of quinolone resistance isolates have mutations 
in quinolone resistance-determining regions. Further search on the genome 












sequence showed that 4 strains possess class 1 integrons in their genomes, and that 
three of four integrons are found to be located in their genomic islands. These 
genomic islands are novel type. This indicates that various integrons containing 
drug resistance genes are spreading among V. cholerae non-O1/non-O139 strains 
through the action of newly-generated genomic islands. 
Key words antibiotic resistance, diarrhea, genome sequence, genomic island, 
integron, Vibrio cholerae, 
Introduction 
Cholera is a life-threatening acute diarrheal disease caused by toxigenic Vibrio 
cholerae in many developing countries (1). Of the 200 serogroups of V. cholerae, 
pandemics and epidemics of cholera have been caused by only V. cholerae O1 and 
O139. V. cholerae belonging to other serogroups are collectively designated as 
non-O1/ non-O139. Vibrios belonging to these multiserogroups do not have 
epidemic potential but have caused several diarrheal outbreaks worldwide (2, 3). It 
has been reported that 5 to 10% of vibriosis in Maryland in the USA has been 
associated with water-/foodborne V. cholerae non-O1/non-O139 strains (4, 5). 












However, the number of laboratories which possess the ability to determine the 
serogroup of V. cholerae non-O1/non-O139 is limited (6). Thus, the relationship 
between the serogroup of V. cholerae non-O1/non-O139 and its pathogenicity has 
remained unclear.  
V. cholerae non-O1/non-O139 strains cause cholera-like acute diarrhea, but 
their virulence and antimicrobial resistance (AMR) mechanism remains also 
unclear (7, 8). However, for the treatment of patients infected with V. cholerae 
non-O1/non-O139 strains, antibiotics have often been recommended (9). The role 
of aquatic ecosystems as reservoirs of antibiotic-resistant bacteria and antibiotic 
resistance genes has been established (10). The possibilities of acquiring AMR in V. 
cholerae are very high, as this bacterium is autochthonous to coastal waters. 
The knowledges on the property involved in pathogenicity of V. cholerae 
non-O1/non-O139 strains obtained are not enough for understanding of the 
pathogenicity of these strains. In order to clear the property, we examined the 
groups and AMR pattern of 25 V. cholerae non-O1/non-O139 strains isolated in 
Kolkata. Subsequently, AMR-encoding genes of these AMR strains and the genetic 












mechanisms to acquire the AMR-encoding genes were examined by analysing the 
whole-genome sequences of these strains. The examination showed that class 1 
integrons encoded in genomic islands (GIs) have been incorporated into the 
chromosomes of some strains of V. cholerae. This indicates that multi-drug 
resistant V. cholerae non-O1/non-O139 strains possessing class 1 integrons will 
spread in our living environment, under the situation of usage of large amount of 
antibiotics.  
MATERIALS AND METODS  
Bacterial identification 
V. cholerae non-O1/non-O139 were isolated from diarrheal patients in Kolkata by 
using standard bacteriological methods. Briefly, the stool samples were cultured in 
alkaline L-broth (pH 8.5) (Becton, Dickinson and Company, NJ, USA) and then on 
thiosulphate citrate bile-salt sucrose (TCBS) agar (Eiken Co., Tokyo, Japan) at 37 
°C for 15 hours. 












Sucrose-fermenting yellow colonies were examined for the oxidase reaction 
using N,N,N’,N’-tetramethyl-p-phenylenediamine (Sigma Aldrich, MD, USA) as 
substrate, and the identification of V. cholerae was confirmed by growth and 
characterization on a triple sugar iron agar slant. O1 or O139 serogroup 
determination was performed with slide agglutination test using commercially 
available antisera (Denkaseiken Co., Ltd., Tokyo). V. cholerae strains showing a 
negative reaction in the slide agglutination test were subjected to PCR targeting 
ompW for the species confirmation of V. cholerae non-O1/non-O139 (11). 
Confirmed V. cholerae non-O1/non-O139 were serogrouped using 206 O 
group-specific serum prepared by the National Institute of Infectious Diseases of 
Japan (6). 
Antimicrobial susceptibility test 
The susceptibility of V. cholerae strains to antibiotics was examined by the disc 
diffusion method according to the Clinical and Laboratory Standards Institute 
guidelines (CLSI, 2014; 2015) (12, 13) using commercially available discs 
containing ampicillin (10 µg), meropenem (10 µg), azithromycin (15 µg), 












chloramphenicol (30 µg), ciprofloxacin (5 µg), doxycycline (30 µg), erythromycin 
(15 µg), furazolidone (100 µg), gentamicin (10 µg), neomycin (30 µg), nalidixic 
acid (30 µg), norfloxacin (10 µg), ofloxacin (5 µg), sulfamethoxazole-trimethoprim 
(23.75 µg/1.25 µg), streptomycin (10 µg), and tetracycline (30 µg) (Becton, 
Dickinson and Company, MD, USA). Escherichia coli (ATCC25922) was used as 
the quality control strain for the assay.  
Extraction of genomic DNA, next-generation sequencing and 
alignment analysis 
The procedures and analysis of genomic DNA was performed using previously 
described method (14). Briefly, genomic DNA was extracted from overnight broth 
cultures of V. cholerae strains using a DNeasy Blood & Tissue Kit (Qiagen 
Sciences, Maryland, USA) according to the manufacturer’s instructions. We 
prepared Illumina libraries using a Nextera XT DNA Library Preparation Kit 
(Illumina) and sequenced paired-end Illumina short reads for each library on HiSeq 
2500 (Illumina) or MiSeq (Illumina) sequencers. The reads were assembled using 
the de novo genome assembly program of CLC Genomics Workbench, and a 












multicontig draft genome was prepared for each sample. Nucleotide sequence data 
were submitted to the DDBJ Sequenced Read Archive (DRA), and each accession 
number is listed in Table S1. 
Sequence analysis for identification of antimicrobial resistance genes was 
performed using BLASTn against contig data. Identification of integron was 
performed using the Integron Database INTEGRALL (http:// integrall.bio.ua.pt/) 
(15). A comparative alignment was performed with reference to sequences of PGI1 
(Proteus mirabilis genomic island 1, GenBank number, KJ411925), AGI1 
(Acinetobacter baumannii genomic island 1, GenBank number, KP054476), and 
GIVchHai8 (Vibrio cholerae HE-45 vcoHE45.contig.17, GenBank number, 
ALED01000018.1). 
Ethics statement 
This study was approved by the Institutional Ethics Committee (IEC) of the 
National Institute of Cholera and Enteric Diseases in Kolkata, India (registration 
number: A-1/2015-IEC). Written consent was obtained from each adult patient or 
parent/guardian of the child patient enrolled in this study. 













Serogroups of non-O1/non-O139 V. cholerae and their 
susceptibility to antibiotics 
We analyzed 25 non-O1/non-O139 strains of V. cholerae isolated from unrelated 
patients in this study. Nineteen serogroups were detected among these 25 strains 
(Table 1). Serogroups O6, O10, O35, O36, O39, and O70 were identified from 2 
patients each, whereas the other serogroups (O8, O11, O12, O27, O34, O37, O44, 
O51, O54, O67, O128, O149 and O178) were identified from a single case of 
diarrhea. Seven of the 25 strains showed antimicrobial resistance to <4 antibiotics 
examined, and 6 strains (IDH-01006, IDH-01215, IDH-02653, IDH-02822, 
IDH-04886, and IDH-05249) showed resistance to >4 antibiotics (Table 1). 
  












Determination of the genome sequence and analysis of genes 
related to antibiotic resistance 
We determined the genomic DNA sequences of these strains by next-generation 
sequencing methods. Genome sequence accession numbers of V. cholerae strains 
analyzed in this study are shown in supplementary Table 1 (Table S1). 
Quinolone resistance gene 
As shown in Table 1, resistance to quinolones was prominent among strains 
examined. Quinolones target DNA gyrase (GyrA and GyrB) and topoisomerase IV 
(ParC and ParE) of bacteria. The binding region of the quinolone antibiotic is very 
important for determining the susceptibility of the bacteria, which is designated the 
quinolone resistance-determining region (QRDR). Mutation(s) in this region has 
been reported to induce a change in the bacteria from a susceptible to a resistant 
phenotype (16). 
We found 10 quinolone-resistant strains in this experiment and examined 
the mutation of the gene in the QRDR of these strains. The mutation was detected 












at two codons, codons at position 83 (codon; AGT) of GyrA and position 85 (TCG) 
of ParC. The former codon was changed to ATT which was codon for isoleucine. 
This mutation (GyrA S83I) was detected in all strains examined (Table 2). As all 10 
V. cholerae strains were resistant to nalidixic acid, the mutation at one site (83rd) 
from serine to isoleucine might convert the phenotype from susceptible to resistant.  
Another mutation in the codon for serine at position 85 (codon; TCG) of 
parC to encode leucine (codon; TTG) was detected in 8 strains (Table 2). Among 
these isolates, five strains (IDH-01006, IDH-01215, IDH-02653, IDH-04886 and 
BCH-03594) showed resistance to norfloxacin and ofloxacin (Tables 1 and 2). This 
suggests that the structure of amino acid residue at position 85 of ParC is related 
with the resistance activity of the bacteria against norfloxacin and ofloxacin. 
However, three strains, IDH-01793, IDH-02822 and IDH-06582, were 
sensitive against norfloxacin and ofloxacin, though the mutation of S85L in ParC 
has generated in these three strains (Tables 1 and 2). On the contrary, the amino 
acid residue at position 85 of IDH-05249 was not mutated, but the strain was 
resistant against norfloxacin and ofloxacin (Tables 1 and 2). These indicate that the 












mutation (ParC S85L) is not sufficient to induce the resistance of V. cholerae 
non-O1/non-O139 against norfloxacin and ofloxacin. Other activities of the 
bacteria, such as influx activity and efflux activity of these quinolones, might be 
deeply involved in the resistance of the bacteria against these quinolones. 
Other antibiotic resistance genes 
In the whole-genome analysis, the presence of other antimicrobial resistance genes 
in V. cholerae strains was identified by BLASTn analysis. As shown in Table 1, 
several antimicrobial resistance genes, such as dfrA (encoding dihydrofolate 
reductase for trimethoprim resistance), sul1 (encoding dihydropteroate synthase for 
sulfonamide resistance), floR (resistance gene for chloramphenicol), tet 
(tetracycline resistance-encoding gene), bla CARB-9 (encoding β-lactamase for 
β-lactam antibiotic resistance), and the mer operon (a mercury resistance operon), 
were detected. There is some correlation between the possession of these antibiotic 
resistance genes and resistance to antibiotics in V. cholerae strains (Table 1). 
  












Sequence-based analysis of transferable AMR genes 
Class 1 integron of isolates 
To analyze how V. cholerae O1 strains acquire AMR genes, we searched for 
integrase genes in the genome sequences (Table 1). These genes includes intI1, 
intI2 and intSXT. These three integrase genes are components of class 1 integron, 
class 2 integron and SXT element, respectively. These integrase genes are involved 
in the horizontal transfer of AMR genes (17, 18). IntI1 was detected in 4 strains 
(IDH-01215, IDH-02822, IDH-03944, and IDH-06641), and one strain, 
IDH-06641, harbored intSXT. None of the strains had intI2. 
Based on this information, the regions encoding integrons of each strain 
were referred to based on genome sequence (Table S1). Our results showed that the 
class 1 integrons of IDH-01215 and IDH-03944 included tni module genes. 
Therefore, these class 1 integrons were regarded as members of a In16 family (Fig 
1) (19). Additionally, as class 1 integrons of IDH-02822 contained IS6100, class 1 
integrons of IDH-02822 might be related with In4 family (Fig 1) (19). As the class 
1 integron of IDH-06641 contains the gene cassette, dfrA15-qacE∆1-sul1, the 












integron was regarded as the member of In192. As the integron of IDH-03944 also 
contains the cassette, dfrA15-qacE∆1-sul1, the integron of IDH-03944, might be a 
member of In192 (15).  
The IS26-mphA-mrx- mphR-IS6100 unit, which was found in the class 1 
integron of IDH-02822, has been shown to be a mobile genetic element (MGE) 
carrying a macrolide-resistance operon (Fig 1) (20). MphA, mrx and mphR encode 
genes for a phosphotransferase, a factor involved in the expression of mphA and a 
negative regulator of transcription of mphA, respectively, and the bacteria 
expressing these genes usually show macrolide-resistance activity. Here, the strain 
IDH-02822 was resistant to EM (erythromycin), which is a macrolide (Table 1). 
Although the other 2 strains, IDH-01215 and IDH-03944, possessed class 1 
integrons, they did not contain MGE carrying the macrolide-resistance operon. 
Therefore, they were sensitive to erythromycin (Table 1). IntSXT of IDH-06641 
did not contain AMR genes. However, it was evident that the SXT element of 
IDH-06641 contained a mer operon encoding the mercury resistance gene (data not 
shown). 












GIs of isolates possessing class 1 integrons 
Although integrons play an important role in the horizontal transfer of AMR genes 
from host bacteria to recipient bacteria, especially in the insertion of the gene into a 
replication gene of the recipient cell, the integron itself does not possess the ability 
to achieve horizontal gene transfer from host bacteria to recipient bacteria (21). To 
accomplish gene transfer, GIs are often involved in the transfer of integrons (17). 
We identified the existence of GIs in 4 strains possessing class 1 integrons 
(IDH-01215, IDH-02822, IDH-03944, and IDH-06641). As two GIs were detected 
in IDH-02822, they were designated GI of IDH-02822-1 and GI of IDH-02822-2 
(Fig 2). These GIs detected in IDH-01215, IDH-02822 and IDH-03944 are located 
in the VC0003 region of each genome. However, no specific chromosomal 
sequence was not found in either end of GI in IDH-06641. 
Framework of GIs 
GIs of IDH-01215, IDH02822-1 and IDH-03944 were located at the 3’ end of trmE 
in the VC0003 region of each genome (Fig 2). The site at which IDH-02822-2 
located was not ben identified. As GIs are usually found at the 3’ end of trmE (18), 












it is likely that IDH-02822-2 is placed adjacent to the 3’ end of IDH-02822-1 and 
that these two GIs (IDH-02822-1 and IDH-02822-2) are arranged in tandem. 
GIs are composed of two regions, a multidrug resistance region (MDR) and 
a core region. To clarify the relation between GIs of V. cholerae and other bacterial 
GIs, we examined the similarity of the core region of the GIs of IDH-01215, 
IDH-02822-1, IDH-02822-2 and IDH-03944. The arrangement of the GIs of 
IDH-01215 and IDH-02822-1 resembled that of AGI1, which is a member of the 
SGI1 (Salmonella genomic island 1) family. The SGI1 family has been found in 
several bacteria, including Salmonella species and Acinetobacter baumannii (22, 
23). 
The arrangement of backbone genes of the GI of IDH-01215 is almost 
similar to that of AGI1, with identity of more than 99%, and the MDR region is 
inserted into the A025 site (Fig 2). However, the backbone of the GI of 
IDH-02822-1 comprised the regions from PGI1 in addition to the region from 
AGI1 (Fig 2). The MDR region of IDH-02822-1 was inserted adjacent to the 
position of A027 site, which is a different position from that in the GI of 












IDH-01215. Interestingly, IDH-02822 possessed another GI, IDH-02822-2, which 
shared 100% homology with GIVchHai8 of the V. cholerae strain HE-45 isolated in 
Haiti (21). The GI of IDH-03944 was also basically composed of the components 
of GIVchHai8 (Fig 2). Both the upstream and downstream terminal ends of the GI 
of IDH-03944 were composed of the gene regions corresponding with those of 
GIVchHai8. 
MDR region 
MDR regions of GIs are variable among vibrios. In the evolution of MDR, multiple 
actions of gene transfer, such as by integrons, ISs and transposons, selfishly 
function to induce the incorporation of AMR genes into this region. This 
phenomenon leads to the formation of various MDR phenotypes. Therefore, it is 
often observed that the compositions of AMR genes in two GIs that possess a 
similar core region are quite different (24). MDR regions in the GIs of IDH-01215, 
IDH-02822-1 and IDH-03944 contained several AMR genes, namely, a dfrA1, sul1 
and mer operon; dfrA1, sul1 and mphA operon; and dfrA15, sul1 and mer operon, 
respectively. This finding shows that the MDR regions of these GIs are composed 












of their corresponding class 1 integrons (Fig 1). These GIs detected in three strains 
are novel types of GI.  
Phylogenetic analysis of integrase 
To check the correlation of GIs examined in this study, phylogenetic analysis of 
integrase genes of these GIs was carried out. The positions of intIDH-02822-1 and 
intIDH-01215 in the phylogenetic tree were close to that of intAGI1 (Fig 3). 
Similarly, the positions of intIDH-02822-2 and intIDH-03944 were close to that of 
intGIVchHai8. These positional relations are coincident with the result from the 
homology search performed for these integrons (Fig 2). 
PGI1 and SGI1 are encoded in Proteus and Salmonella, respectively and 
are regarded as the source of other bacterial integron 1 sequences. IntPGI1 was 
placed at a position distant from those of intIDH-02822-2 and intIDH-03944. The 
two integrases encoded in PGI1 and SGI1 were positioned very close in the 
phylogenetic tree (Fig 3). This result indicates that mutual transfer of integron 1 
between Proteus and Salmonella generated during the initial stage of integron 1 












evolution, followed by its transfer into V. cholerae non-O1/non-O139 strains, with 
some changes in the nucleotide sequence. 
DISCUSSION  
The hospitalized patients infected with V. cholerae non-O1/non-O139 strains 
presented acute diarrhea resembling cholera caused by V. cholerae O1. Very limited 
studies have been carried out to investigate the virulence and AMR of V. cholerae 
strains other than O1 and O139 serogroups. The Indian subcontinent is said to be 
the homeland of cholera and the source of several variants of V. cholerae O1 
(25-27). Therefore, much attention has to be paid to clinical strains of V. cholerae 
showing antibiotic resistance. With this background, we examined the AMR pattern 
in V. cholerae non-O1/non-O139 isolates and analyzed the genes responsible for 
the AMR. 
In the analysis of quinolone resistance gene, we noted the mutation in GyrA 
at position 83 (S83I) and ParC at position 85 (S85L). The former mutation caused 
the resistance of every bacteria examined to NA. It can be concluded that serine 












residue at position 83 of GyrA is an important residue for NA to express the 
activity.  
However, the effect of mutation of ParC S85L on the resistance of bacteria 
was not uniform and the mutation was not always required to express the resistance 
against norfloxacin and ofloxacin as observed in IDH-05249 (Table 2).  
We examined the sensitivity of bacteria by disc diffusion method and 
regarded the bacteria expressing resistance to antibiotics at the level of more than 
intermediate as resistant bacteria to the antibiotics. The bacteria expressing 
resistance at low level was regarded as sensitive bacteria in this assay, though they 
exhibited weak resistance. To conclude the resistance of these strains against 
norfloxacin and ofloxacin, further assays, such as determination of minimal 
inhibitory concentration, is necessary. Based on the data obtained, we should 
discuss the function of amino acid residue at position 85 of ParC. 
We think other possibilities. The mutations to change the resistance of the 
bacteria to norfloxacin and ofloxacin may happen in some strains. To find out such 












mutations, more careful searching of gene sequence is necessary. To carry out these 
searching, the search using other tools such as ResFinder is necessary. 
In this study, 4 V. cholerae non-O1/non-O139 strains (IDH-01215, 
IDH-02822, IDH-03944 and IDH-06641) had resistance-encoding genes in class 1 
integrons. This integron seems to play an important role in the acquisition of AMR 
in V. cholerae non-O1/non-O139 strains as well as in other bacteria (28-31). 
As class 1 integrons cannot transfer on their own, other MGEs, such as GIs 
and/or conjugative plasmids, are necessary for their transfer to other bacteria (17, 
21). We detected 3 types of GIs, including class 1 integrons inserted at trmE that 
differed from other reports (21). Though the presence of class 1 integrons has been 
reported in other V. cholerae non-O1/non-O139 isolates (28-30), our integrons are 
quite different from those integrons. Thus, our GIs are novel types of GI. It 
indicates that new type of GI has constantly emerged in V. cholerae 
non-O1/non-O139 strains and V. cholerae non-O1/non-O139 strains containing 
these new GIs have already spread to a certain extent. 












Apart from Salmonella enterica, the int gene encoding a site-specific 
recombinase family in SGI1 has been reported in many species, including P. 
mirabilis and A. baumannii (23, 32-34). Moreover, the SGI1 family may contain 
the NDM β-lactamase gene (35, 36), and hence, the SGI1 family has the potential 
to grow up the gene cluster containing several AMR-encoding genes in several 
bacterial species.  
Our results indicate that V. cholerae can also acquire the SGI1 
family-encoding AMR genes from other species by horizontal gene transfer. We 
have shown that some strains of V. cholerae can contain two GIs. This result 
suggests that V. cholerae non-O1/non-O139 strains have the potential to generate 
strains that are highly resistant to several antimicrobials. 
The acquisition of AMR genes in V. cholerae O1 which is mediated by the 
SXT element and IncA/C conjugative plasmid has been reported (37). Further 
studies showed that other genetic factors are involved in the acquisition SXT 
element (38). In this study, we have showed that GIs containing class 1 integrons in 
the downstream region of trmE are also important factors for antimicrobial 












resistance in V. cholerae non-O1/non-O139 strains. The site where GIs locate is 
different from the site where the SXT element is inserted (39). V. cholerae O1 
containing both these GIs and the IncA/C plasmid has not been reported, yet. 
However, as shown in this study, a certain number of non-O1/non-O139 V. 
cholerae have already acquired GIs. It may happen that non-O1/non-O139 V. 
cholerae strains acquired both GIs and the IncA/C plasmid appear and that the 
number of these strains increases under antibiotic stress in near future. It is 
important to monitor the appearance of these types of V. cholerae 
non-O1/non-O139 and prevent the generation of V. cholerae O1/O139 with 
extensive drug resistance. 
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Figures 
Fig 1. Components Constituting the Class 1 Integron of the Strains IDH-01215, 
IDH-02822, IDH-03944 and IDH-06641. 
 












Fig. 2. Components of the GIs detected in isolates and comparison with related 
GIs. GIs in strains were detected by homology research as described in the text. The 
arrangements of PGI1, AGI1 and GIVchHai8 were designated from GenBank accession 
numbers KJ411925, KP054476 and ALED01000018.1, respectively. 
 












Fig. 3. Molecular phylogenetic analysis of the integrase genes encoded in 
genomic islands inserted at trmE. Integrase genes encoded in each genomic island 
inserted at trmE were analyzed to draw phylogenetic trees. The analysis was performed 
by the Clustal W (https://www.genome.jp/tools-bin/clustalw) algorithm using default 
parameters. 
 
List of Abbreviations: 
AM, ampicillin; AMR, antimicrobial resistance; CIP, ciprofloxacin; CLSI, 
clinical and laboratory standards institute; EM, erythromycin; GIs, genomic 
islands; MDR, multidrug resistance region; MGE, mobile genetic element; 












NA, nalidixic acid; NDM, new delhi metallo-β-lactamase; NOR, norfloxacin; 
OFX, ofloxacin; QRDR, quinolone resistance-determining region; SM, 
streptomycin; SXT, sulfamethoxazole with trimethoprim; TCBS, thiosulphate 
citrate bile-salt sucrose; TE, tetracycline. 
Table 1. Detection of O-antigen, antimicrobial resistance, antimicrobial 
resistance-encoding gene and integrase gene of non-O1/non-O139 V. cholerae 
 
Strain Year O-antigen Resistance 
profile† 
Antimicrobial 
resistance-encoding gene ‡ 
Integrase 
gene 
IDH-00012 2007 O149 SXT dfrA6(31) n. d.  
IDH-00024 2007 O11 None n. d. n. d. 
IDH-00749 2007 O39 None n. d. n. d. 
IDH-00812 2008 O70 None n. d. n. d. 
IDH-00828 2008 O67 None n. d. n. d. 
IDH-00904 2008 O70 None n. d. n. d. 
IDH-01006 2008 O6 CIP, NA, NOR, 
OFX 
m-gyrA, m-parCe n. d. 












IDH-01215 2008 O37 CIP, NA, NOR, 
OFX 
dfrA1, sul1, merRTPFADE, 
m-gyrA, m-parC 
intI1 
IDH-01460 2009 O8 None n. d. n. d. 
IDH-01580 2009 O39 None n. d. n. d. 
IDH-01620 2009 O27 None n. d. n. d. 
IDH-01793 2009 O34 NA m-gyrA, m-parC n. d. 
IDH-02372 2009 O6 None n. d. n. d. 
IDH-02653 2009 O51 CIP, NA, NOR, 
OFX, TE 
sul2, tetA(D), m-gyrA, m- 
parC 
n. d. 
IDH-02822 2010 O35 EM, NA, SM, 
SXT, TE 
dfrA1, sul1, sul2, floR, 
mphA, mrx, mphR, m-gyrA, 
m-parC 
intI1 
IDH-03148 2010 O128 None n. d. n. d. 
IDH-03257 2010 O178 None n. d. n. d. 
IDH-03297 2010 O35 None n. d. n. d. 
IDH-03944 2011 O44 NA, SM, SXT dfrA15, sul1, floR, 
merRTPFADE, m-gyrA 
intI1 












IDH-04713 2012 O54 SM dfrA6(31) n. d. 
IDH-04886 2012 O12 CIP, NA, NOR, 
OFX, SXT 
dfrA6(31), m-gyrA, m-parC n. d. 
BCH-03594 2013 O36 NA, NOR, OFX m-gyrA, m-parC n. d. 
IDH-05249 2013 O36 CIP, NA, NOR, 
OFX 
m-gyrA n. d. 
IDH-06582 2014 O10 NA, SXT dfrA6(31), m-gyrA, m-parC n. d. 




†Antibiotics to which strains were resistant with activity of more than intermediate 
action. None: no antibiotics to which the strain examined is resistant. 
‡n.d.: not detected. m-gyrA and m-parC are mutant gyrA and mutant parC genes, 
respectively, described in Table 2.  
  












Table 2. Mutations in the QRDR of quinolone-resistant V. cholerae strains 
Mutation in the QRDR Strain Resistance profile 
GyrA S83I IDH-03944 NA 
GyrA S83I IDH-05249 NA, NOR, OFX, CIP 
GyrA S83I and ParC S85L IDH-01006 NA, NOR, OFX, CIP 
GyrA S83I and ParC S85L IDH-01215 NA, NOR, OFX, CIP 
GyrA S83I and ParC S85L IDH-01793 NA 
GyrA S83I and ParC S85L IDH-02653 NA, NOR, OFX, CIP 
GyrA S83I and ParC S85L IDH-02822 NA 
GyrA S83I and ParC S85L IDH-04886 NA, NOR, OFX, CIP 
GyrA S83I and ParC S85L BCH-03594 NA, NOR, OFX 
GyrA S83I and ParC S85L IDH-06582 NA 
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